207 related articles for article (PubMed ID: 23116461)
41. Inhibition of melanocortin 1 receptor slows melanoma growth, reduces tumor heterogeneity and increases survival.
Kansal RG; McCravy MS; Basham JH; Earl JA; McMurray SL; Starner CJ; Whitt MA; Albritton LM
Oncotarget; 2016 May; 7(18):26331-45. PubMed ID: 27028866
[TBL] [Abstract][Full Text] [Related]
42. Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH-Peptide Conjugates.
Szabó I; Biri-Kovács B; Vári B; Ranđelović I; Vári-Mező D; Juhász É; Halmos G; Bősze S; Tóvári J; Mező G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256168
[TBL] [Abstract][Full Text] [Related]
43. Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.
Jiang H; Kasten BB; Liu H; Qi S; Liu Y; Tian M; Barnes CL; Zhang H; Cheng Z; Benny PD
Bioconjug Chem; 2012 Nov; 23(11):2300-12. PubMed ID: 23110503
[TBL] [Abstract][Full Text] [Related]
44. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres.
Lu W; Xiong C; Zhang G; Huang Q; Zhang R; Zhang JZ; Li C
Clin Cancer Res; 2009 Feb; 15(3):876-86. PubMed ID: 19188158
[TBL] [Abstract][Full Text] [Related]
45.
Zhang C; Zhang Z; Merkens H; Zeisler J; Colpo N; Hundal-Jabal N; Perrin DM; Lin KS; Bénard F
Sci Rep; 2019 Sep; 9(1):13575. PubMed ID: 31537869
[TBL] [Abstract][Full Text] [Related]
46. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.
Herraiz C; Journé F; Abdel-Malek Z; Ghanem G; Jiménez-Cervantes C; García-Borrón JC
Mol Endocrinol; 2011 Jan; 25(1):138-56. PubMed ID: 21084381
[TBL] [Abstract][Full Text] [Related]
47. Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors.
Lu W; Xiong C; Zhang R; Shi L; Huang M; Zhang G; Song S; Huang Q; Liu GY; Li C
J Control Release; 2012 Aug; 161(3):959-66. PubMed ID: 22617522
[TBL] [Abstract][Full Text] [Related]
48. Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.
Chen F; Zhang X; Ma K; Madajewski B; Benezra M; Zhang L; Phillips E; Turker MZ; Gallazzi F; Penate-Medina O; Overholtzer M; Pauliah M; Gonen M; Zanzonico P; Wiesner U; Bradbury MS; Quinn TP
ACS Appl Mater Interfaces; 2018 Feb; 10(5):4379-4393. PubMed ID: 29058865
[TBL] [Abstract][Full Text] [Related]
49. Malignant melanoma and melanocortin 1 receptor.
Rosenkranz AA; Slastnikova TA; Durymanov MO; Sobolev AS
Biochemistry (Mosc); 2013 Nov; 78(11):1228-37. PubMed ID: 24460937
[TBL] [Abstract][Full Text] [Related]
50. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
51. Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma.
Dall'Olmo L; Papa N; Surdo NC; Marigo I; Mocellin S
J Transl Med; 2023 Aug; 21(1):562. PubMed ID: 37608347
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
53. Functional Characterization of MC1R-TUBB3 Intergenic Splice Variants of the Human Melanocortin 1 Receptor.
Herraiz C; Olivares C; Castejón-Griñán M; Abrisqueta M; Jiménez-Cervantes C; García-Borrón JC
PLoS One; 2015; 10(12):e0144757. PubMed ID: 26657157
[TBL] [Abstract][Full Text] [Related]
54. Regulation of melanocortin 1 receptor in allergic rhinitis in vitro and in vivo.
Kleiner S; Braunstahl GJ; Rüdrich U; Gehring M; Eiz-Vesper B; Luger TA; Steelant B; Seys SF; Kapp A; Böhm M; Hellings PW; Raap U
Clin Exp Allergy; 2016 Aug; 46(8):1066-74. PubMed ID: 27196703
[TBL] [Abstract][Full Text] [Related]
55. Melanocytes expressing MC1R polymorphisms associated with red hair color have altered MSH-ligand activated pigmentary responses in coculture with keratinocytes.
Roberts DW; Newton RA; Leonard JH; Sturm RA
J Cell Physiol; 2008 May; 215(2):344-55. PubMed ID: 17960564
[TBL] [Abstract][Full Text] [Related]
56. PGC-1α in Melanoma: A Key Factor for Antioxidant Response and Mitochondrial Function.
Torrens-Mas M; González-Hedström D; Abrisqueta M; Roca P; Oliver J; Sastre-Serra J
J Cell Biochem; 2017 Dec; 118(12):4404-4413. PubMed ID: 28452072
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
58. Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.
Zhang C; Lin KS; Bénard F
Mol Imaging; 2017; 16():1536012117737919. PubMed ID: 29182034
[TBL] [Abstract][Full Text] [Related]
59. Three novel human sporadic melanoma cell lines: signaling pathways controlled by MC1R, BRAF and β-catenins.
Zanna P; Maida I; Grieco C; Guida S; Turpin Sevilla MC; De Summa S; Tommasi S; Vena GA; Filotico R; Guida G
J Biol Regul Homeost Agents; 2013; 27(1):131-41. PubMed ID: 23489693
[TBL] [Abstract][Full Text] [Related]
60. Visualization of melanoma tumor with lectin-conjugated rare-earth doped fluoride nanocrystals.
Dumych T; Lutsyk M; Banski M; Yashchenko A; Sojka B; Horbay R; Lutsyk A; Stoika R; Misiewicz J; Podhorodecki A; Bilyy R
Croat Med J; 2014 Jun; 55(3):186-94. PubMed ID: 24891277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
